These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 16860053)
1. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053 [TBL] [Abstract][Full Text] [Related]
2. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids. Dhanaraju MD; Gopinath D; Ahmed MR; Jayakumar R; Vamsadhara C J Biomed Mater Res A; 2006 Jan; 76(1):63-72. PubMed ID: 16108044 [TBL] [Abstract][Full Text] [Related]
3. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats. Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239 [TBL] [Abstract][Full Text] [Related]
5. Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies. Gao P; Xu H; Ding P; Gao Q; Sun J; Chen D Int J Pharm; 2007 Feb; 330(1-2):1-5. PubMed ID: 16987624 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease. Liu WH; Song JL; Liu K; Chu DF; Li YX J Control Release; 2005 Oct; 107(3):417-27. PubMed ID: 16154224 [TBL] [Abstract][Full Text] [Related]
7. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
8. Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Stern M; Ulrich K; Geddes DM; Alton EW Gene Ther; 2003 Aug; 10(16):1282-8. PubMed ID: 12883524 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611 [TBL] [Abstract][Full Text] [Related]
10. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres. Seo SA; Khang G; Rhee JM; Kim J; Lee HB J Microencapsul; 2003; 20(5):569-79. PubMed ID: 12909542 [TBL] [Abstract][Full Text] [Related]
11. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
12. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
13. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment. Pagar KP; Vavia PR Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187 [TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Norton LW; Tegnell E; Toporek SS; Reichert WM Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824 [TBL] [Abstract][Full Text] [Related]
15. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
16. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres. Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study. He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114 [TBL] [Abstract][Full Text] [Related]
19. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Giordano GG; Refojo MF; Arroyo MH Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796 [TBL] [Abstract][Full Text] [Related]
20. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]